AzTrials
AzTrials

Respiratory Distress Syndrome In Premature InfantsNCT02770976

Respiratory Pattern During Neurally Adjusted Ventilator Assist (NAVA) in Preterm Infants

A study testing Increasing and decreasing NAVA levels with 10-min intervals in people with Respiratory Distress Syndrome In Premature Infants and Preterm Infants, run by Inha University Hospital at 1 site in South Korea.

Completed

Finished. The study has ended and is not enrolling. Results may be posted on the official record.

Official record
Search all trials

Trial summary

This study is to investigate the effect of a wide range of assistance levels on respiratory pattern, breathing variability including tidal volume and peak inspiratory pressure during neurally adjusted ventilatory assist (NAVA) in preterm infants. Read more about this study

Who is it for?
Any age
What is being tested?
Increasing and decreasing NAVA levels with 10-min intervals
Type of treatment
Medical device
Could I receive a placebo?
No, everyone receives an active treatment
How many people
14 participants
Where
1 siteSouth Korea
Study dates
May 2016to 9 Mar 2017
Phase
Interventional
Are there results?
None posted in the registry

Key requirements

Who can take part, as listed by the sponsor. Only the study team can confirm whether you are eligible, so take this list to your doctor.

  • Ages Any age
  • All sexes
  • No healthy volunteers
  • Child, Adult, Older adult

Who may be able to join

  • preterm infants born before 36 weeks of gestational age
  • who received mechanical ventilatory care through the endotracheal tube at least 24 hours for respiratory distress
  • no use of anesthetics or analgetics

Who cannot join

  • with major congenital anomalies (facial, gastrointestinal tract, cardiac, etc)
  • with phrenic nerve palsy or injuries

Trial locations and contacts

1 site in 1 country.

South Korea1 site
  • Inha University Hospital

    Incheon, 22332

Other trials in South Korea

About this study

This study is to investigate the effect of a wide range of assistance levels on respiratory pattern, breathing variability including tidal volume and peak inspiratory pressure during neurally adjusted ventilatory assist (NAVA) in preterm infants. The investigators also aim to explore whether the effects of NAVA on the electrical activity of diaphragm (Edi) signal amplitude, work of breathing and comfort of preterm infants.

Being tested
Increasing and decreasing NAVA levels with 10-min intervals
Medical subject headings
Respiratory Distress Syndrome In Premature Infants

What participants receive

What participants receive. In a randomised study each person is assigned to one group by chance.

  • Increasing and decreasing NAVA levels with 10-min intervalsDevice

Study groups in NCT02770976
Study groupRoleWhat they receive
NAVAExperimentalSeven increasing and decreasing NAVA levels (0.5, 1, 1.5, 2, 2.5, 3, 3.5, 4, 3.5, 3.0, 2.5, 2.0, 1.5, 1.0 and 0.5 cmH2O/uV) will applied to 20 preterm infants each for 10 minutes.
Receives: Device: Increasing and decreasing NAVA levels with 10-min intervals

What is being measured

The primary outcome is the main question the study is designed to answer.

  1. maximum Edi

    mean of recorded maximum electrical activities in the middle 2 min duration out of the total 10 min period

    Measured: the middle 2 minutes duration out of the total interval of 10 minutes

Secondary outcomes (5)
  1. comfort score

    calculated score of premature infant pain profile (PIPP) from the recorded video, heart rates and oxygen saturation

    Measured: the 5-min point in the total 10-min period

  2. peak inspiratory pressure

    mean of recorded peak inspiratory pressures in the middle 2 min duration out of the total 10 min period

    Measured: the middle 2 minutes duration out of the total interval of 10 minutes

  3. tidal volume

    mean of recorded expiratory tidal volumes in the middle 2 min duration out of the total 10 min period

    Measured: the middle 2 minutes duration out of the total interval of 10 minutes

  4. inspiratory time in excess

    mean of calculated excessive inspiratory times from the calculation ((ventilator pressurization time-neural inspiratory time)/neural inspiratory time) from the middle 2 min duration out of the total 10 min period

    Measured: the middle 2 minutes duration out of the total interval of 10 minutes

  5. electrical time product

    mean of calculated electrical time product from the middle 2 min duration out of the total 10 min period

    Measured: the middle 2 minutes duration out of the total interval of 10 minutes

Timeline

From the start of the study to its completion; the mark is today. Estimated dates are the sponsor’s plan.

  1. First posted12 May 2016 (estimated)
  2. Study startMay 2016
  3. Primary completion9 Mar 2017
  4. Study completion9 Mar 2017

Resources

More details

For doctors and researchers: how the study is designed, who runs it, and its registry IDs.

Study design
Study type
Interventional
Phase
Phase N/A
Primary purpose
Supportive care
Allocation
Not applicable
Intervention model
Single group
Masking
None (open label)
Enrolment
14 participants (actual)
IDs, dates and publications
ClinicalTrials.gov ID
NCT02770976
Sponsor's protocol ID
NAVA-03-INV
Status last verified
Jan 2018
First submitted
10 May 2016
Last updated
26 Jan 2018
Results posted
No

Publications

  • Nam SK, Lee J, Jun YH. Neural feedback is insufficient in preterm infants during neurally adjusted ventilatory assist. Pediatr Pulmonol. 2019 Aug;54(8):1277-1283. doi: 10.1002/ppul.24352. Epub 2019 May 11.

    PubMed 31077579

Questions about this trial

What is this clinical trial studying?

A study testing Increasing and decreasing NAVA levels with 10-min intervals in people with Respiratory Distress Syndrome In Premature Infants and Preterm Infants, run by Inha University Hospital at 1 site in South Korea.

The full registered description is in the About this study section and the official record.

Who may be eligible to take part?

The sponsor lists 3 inclusion and 2 exclusion criteria. Eligibility is decided by the study team after screening, so read the full criteria and contact a listed site.

Is this clinical trial currently recruiting?

The record says: finished, as of the sponsor's last update on 26 Jan 2018. Status can change between updates, so confirm with the study contact before making plans.

Where is the study taking place?

The record lists 1 site in South Korea. Whether a site is taking part right now should be confirmed with that site. See every site.

What are the possible benefits and risks?

They depend on the study and the treatment, and no study can promise a benefit. The study team explains the known risks during informed consent, before anyone joins; the record itself does not list them.

Are results available for this study?

The study is completed, but results are not available in the source record. That does not mean the treatment did or did not work.

How can a doctor refer a patient or contact the research team?

The record lists no contact. The official record names the sponsor, who can be asked directly. AzTrials does not enrol participants or take referrals.

What does the primary outcome measure?

maximum Edi (time frame: the middle 2 minutes duration out of the total interval of 10 minutes). It is what the study was designed to measure, not a finding.

Where can I read the original study information?

On the ClinicalTrials.gov record for NCT02770976, which also lists 1 linked publication.

Does a listing mean the treatment is approved or proven to work?

No. A listing means the study is registered. It does not show that the treatment is safe, works, or is approved by a regulator.

How often is this information updated?

AzTrials copies changed records from ClinicalTrials.gov every night and reloads the whole registry every week. The sponsor last updated this record on 26 Jan 2018; AzTrials last refreshed its copy on 31 Oct 2026.

Free account

Keep searching with a free account

You’ve used your 3 free searches for this session. Log in or create a free AzTrials account to keep searching clinical trials and save the ones you want to follow.

Create a free accountLog in